MARKET

ZOM

ZOM

Zomed Pharm
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3520
-0.0209
-5.60%
Opening 12:35 12/10 EST
OPEN
0.3692
PREV CLOSE
0.3729
HIGH
0.3692
LOW
0.3500
VOLUME
22.36K
TURNOVER
--
52 WEEK HIGH
1.600
52 WEEK LOW
0.1996
MARKET CAP
38.03M
P/E (TTM)
-1.3968
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZOM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZOM News

  • Zomedica Announces Management Changes
  • GlobeNewswire.12/03 11:55
  • Zomedica Shares Spike To Session High, Up 12.6% As Hearing Co. Granted Int'l. Patent Number '877 For 'Compositions And Methods For Identifying Cancer Cells'
  • Benzinga.11/14 16:25
  • Zomedica Expands ZM-006 Pilot Efficacy Study
  • GlobeNewswire.11/13 11:55
  • Zomedica Pharmaceuticals Q3 EPS $(0.03) Down From $(0.02) YoY
  • Benzinga.11/12 21:55

More

Industry

Pharmaceuticals
+0.69%
Pharmaceuticals & Medical Research
+0.69%

Hot Stocks

Name
Price
%Change

About ZOM

Zomedica Pharmaceuticals Corp., formerly Wise Oakwood Ventures Inc., is a veterinary pharmaceutical and healthcare solutions company. The Company's principal business relates to the discovery, development and commercialization of pharmaceuticals for the companion pet. The Company's first product candidate, ZM-012, is a tablet formulation of metronidazole, an anti-infective for the treatment of diarrhea in canines (dogs). The Company's second product candidate, ZM-006, is a transdermal gel that delivers its active pharmaceutical ingredient, methimazole, which is used in veterinary medicine to treat hyperthyroidism in felines (cats). The Company's third product candidate, ZM-007, is an oral suspension formulation of metronidazole for accurate dosing of small dog breeds and puppies. The Company's fourth product candidate, ZM-011 is a transdermal gel of fluoxetine, Prozac, prescribed to treat cat behavioral disorders, such as inappropriate urination.
More

Webull offers Zomedica Pharmaceuticals Corp (ZOM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.